Medtronic plc Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
Medtronic plc (MDT) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $290.00 million for the 12-month period ending 2026-04-24, per its 10-K filed 2026-06-18.
Financial Statements › Notes › Leases
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2026-06-18
- Medtronic plc right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2020-04-24 was -$4.00M.
- Medtronic plc right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2020-01-24 was $73.00M.
- Medtronic plc right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2019-10-25 was $56.00M.
- Medtronic plc right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2019-07-26 was $49.00M.
- Medtronic plc right-of-use asset obtained in exchange for operating lease liability for fiscal 2026 was $290.00M, a 3.20% increase from fiscal 2025.
- Medtronic plc right-of-use asset obtained in exchange for operating lease liability for fiscal 2025 was $281.00M, a 27.73% increase from fiscal 2024.
- Medtronic plc right-of-use asset obtained in exchange for operating lease liability for fiscal 2024 was $220.00M, a 47.24% decline from fiscal 2023.
- Medtronic plc right-of-use asset obtained in exchange for operating lease liability for fiscal 2023 was $417.00M, a 434.62% increase from fiscal 2022.
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-04-24 | $290.00M 10-K · filed 2026-06-18 | |||
| 2025-04-25 | $281.00M 10-K · filed 2026-06-18 | |||
| 2024-04-26 | $220.00M 10-K · filed 2026-06-18 | |||
| 2023-04-28 | $417.00M 10-K · filed 2025-06-20 | |||
| 2022-04-29 | $78.00M 10-K · filed 2024-06-20 | |||
| 2021-04-30 | $230.00M 10-K · filed 2023-06-22 | |||
| 2020-04-24 | -$4.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-06-23 | $69.00M derived: sum of 2 quarters · filed 2022-06-23 | $125.00M derived: sum of 3 quarters · filed 2022-06-23 | $174.00M 10-K · filed 2022-06-23 |
| 2020-01-24 | $73.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-02-28 | $129.00M derived: sum of 2 quarters · filed 2020-02-28 | $178.00M 10-Q · filed 2020-02-28 | |
| 2019-10-25 | $56.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-12-03 | $105.00M 10-Q · filed 2019-12-03 | ||
| 2019-07-26 | $49.00M 10-Q · filed 2019-08-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B |